Erin Wright
Stock Analyst at Morgan Stanley
(4.43)
# 1,634
Out of 5,182 analysts
261
Total ratings
63.04%
Success rate
13.91%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Maintains: Underweight | $61 → $64 | $77.20 | -17.10% | 7 | Apr 24, 2026 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $128 → $146 | $179.22 | -18.54% | 5 | Apr 24, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $19 → $21 | $26.77 | -21.55% | 10 | Apr 24, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $169 → $188 | $184.70 | +1.79% | 27 | Apr 24, 2026 | |
| PSX Phillips 66 | Upgrades: Overweight | $147 → $174 | $164.10 | +6.03% | 4 | Apr 24, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $375 → $395 | $354.69 | +11.36% | 4 | Apr 22, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $40 → $48 | $48.57 | -1.17% | 5 | Mar 4, 2026 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $22 → $24 | $22.09 | +8.65% | 13 | Feb 25, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $223.62 | -22.19% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $310.16 | +28.97% | 2 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $224 → $245 | $202.34 | +21.08% | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $27.93 | +36.05% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $352 | $356.13 | -1.16% | 5 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $93 | $78.36 | +18.68% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $117.87 | +48.47% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $828.32 | +10.59% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $574.95 | +40.01% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $56.14 | -53.69% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $282.58 | +38.01% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.30 | +39.13% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.96 | +92.31% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $196.63 | -12.53% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $263.43 | +13.88% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $7.97 | +426.98% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $180.62 | +59.45% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $171.23 | +105.57% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.68 | +1,095.65% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $421.37 | -57.04% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $84.11 | -79.79% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $25.22 | +379.78% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $468.04 | +23.92% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $6.24 | +460.90% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $103.21 | +98.62% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $15.60 | -29.49% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $163.84 | -4.17% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $513.35 | -40.00% | 1 | Oct 25, 2017 |
Henry Schein
Apr 24, 2026
Maintains: Underweight
Price Target: $61 → $64
Current: $77.20
Upside: -17.10%
Molina Healthcare
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $128 → $146
Current: $179.22
Upside: -18.54%
Envista Holdings
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $26.77
Upside: -21.55%
Align Technology
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $169 → $188
Current: $184.70
Upside: +1.79%
Phillips 66
Apr 24, 2026
Upgrades: Overweight
Price Target: $147 → $174
Current: $164.10
Upside: +6.03%
UnitedHealth Group
Apr 22, 2026
Maintains: Overweight
Price Target: $375 → $395
Current: $354.69
Upside: +11.36%
BrightSpring Health Services
Mar 4, 2026
Maintains: Overweight
Price Target: $40 → $48
Current: $48.57
Upside: -1.17%
Elanco Animal Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $22.09
Upside: +8.65%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $223.62
Upside: -22.19%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $310.16
Upside: +28.97%
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $202.34
Upside: +21.08%
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $27.93
Upside: +36.05%
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $356.13
Upside: -1.16%
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $78.36
Upside: +18.68%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $117.87
Upside: +48.47%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $828.32
Upside: +10.59%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $574.95
Upside: +40.01%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $56.14
Upside: -53.69%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $282.58
Upside: +38.01%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.30
Upside: +39.13%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.96
Upside: +92.31%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $196.63
Upside: -12.53%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $263.43
Upside: +13.88%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $7.97
Upside: +426.98%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $180.62
Upside: +59.45%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $171.23
Upside: +105.57%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.68
Upside: +1,095.65%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $421.37
Upside: -57.04%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $84.11
Upside: -79.79%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $25.22
Upside: +379.78%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $468.04
Upside: +23.92%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $6.24
Upside: +460.90%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $103.21
Upside: +98.62%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $15.60
Upside: -29.49%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $163.84
Upside: -4.17%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $513.35
Upside: -40.00%